The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


4 milligram(s) Powder and solvent for solution for injection

Novartis Europharm LimitedEU/1/01/176/003

Main Information

Trade NameZometa
Active SubstancesZoledronic acid
Strength4 milligram(s)
Dosage FormPowder and solvent for solution for injection
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/01/176/003

Group Information

ATC CodeM05BA08 zoledronic acid


Licence Issued20/03/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - Patient

« Back